Melodia (Ethinylestradiol, Gestodene | Lactose Monohydrate)

Ethinylestradiol (an estrogen) and gestodene (a progestogen) work together to suppress the hypothalamic‑pituitary‑gonadal axis, reducing the release of LH and FSH. This prevents ovulation, thickens cervical mucus, and alters the endometrial lining, creating conditions that inhibit sperm penetration and implantation.

The dosing regimen for Melodia is determined by the prescribing healthcare professional. Typically, it is taken as one tablet daily at the same time each day, but the exact schedule and any special instructions must be provided by the prescriber.

Melodia is not intended for use during pregnancy and should be discontinued if pregnancy is confirmed. While limited data exist for breastfeeding, the progestin component may affect milk production, and clinicians usually advise caution and consider alternative contraception for nursing mothers.

To order Melodia, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Melodia contains gestodene, a third‑generation progestogen, which is associated with a lower incidence of androgenic side effects compared with older agents such as levonorgestrel. Its efficacy in preventing pregnancy is comparable to other combined pills, while the side‑effect profile may differ slightly, especially regarding lipid metabolism and mood changes.

Melodia tablets should be stored at ambient temperature, preferably below 25 °C, in the original blister pack or container. Protect them from excess moisture, direct sunlight, and extreme heat to maintain potency throughout the shelf life.

Melodia is taken orally, usually as a single tablet each day. It should be swallowed with water, preferably at the same time each day, and not chewed or broken. Consistent daily intake maximizes contraceptive effectiveness.

The most serious risks include venous thromboembolism (deep‑vein thrombosis or pulmonary embolism), arterial thrombosis leading to stroke or myocardial infarction, severe hypertension, and rare liver disorders such as hepatic adenoma. Patients should be educated to seek immediate medical attention if they experience symptoms such as unexplained leg pain, chest pain, severe headache, or visual changes.

Melodia is contraindicated in women with a history of thromboembolic disorders, active or past liver disease, known or suspected breast cancer, uncontrolled hypertension, or those who are pregnant. It should also be avoided in smokers over 35 years of age and in individuals with known hypersensitivity to any component of the tablet.